Pura Vida Investments’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-531,229
Closed -$9.08M 346
2021
Q2
$9.08M Sell
531,229
-378,431
-42% -$7.08M 0.28% 82
2021
Q1
$19M Buy
909,660
+53,937
+6% +$1.24M 0.54% 36
2020
Q4
$19.6M Sell
855,723
-5,093
-0.6% -$97K 0.71% 32
2020
Q3
$14M Sell
860,816
-163,558
-16% -$2.96M 0.72% 28
2020
Q2
$13.9M Buy
1,024,374
+342,509
+50% +$3.98M 1.33% 21
2020
Q1
$8.08M Sell
681,865
-48,495
-7% -$1.08M 0.96% 28
2019
Q4
$18.2M Buy
730,360
+60,360
+9% +$1.22M 1.6% 19
2019
Q3
$11.4M Buy
670,000
+359,174
+116% +$6.54M 1.95% 20
2019
Q2
$7.07M Buy
310,826
+115,000
+59% +$3.1M 1.07% 31
2019
Q1
$6.3M Buy
195,826
+5,491
+3% +$170K 0.9% 33
2018
Q4
$5.36M Buy
190,335
+106,808
+128% +$3.13M 1.07% 19
2018
Q3
$2.4M Buy
83,527
+11,027
+15% +$331K 0.51% 56
2018
Q2
$2.71M Sell
72,500
-37,500
-34% -$1.47M 1.09% 31
2018
Q1
$4.32M Buy
110,000
+10,000
+10% +$365K 2.55% 13
2017
Q4
$3.24M Sell
100,000
-300,000
-75% -$9M 1.36% 30
2017
Q3
$12.5M Buy
400,000
+202,502
+103% +$5.99M 2.22% 14
2017
Q2
$5.52M Sell
197,498
-190,424
-49% -$4.31M 2.19% 19
2017
Q1
$6.65M Buy
+387,922
New +$5.43M 1.97% 22
2016
Q4
Sell
-275,000
Closed -$3.56M 104
2016
Q3
$4.36M Buy
275,000
+60,000
+28% +$904K 1.32% 29
2016
Q2
$2.78M Buy
+215,000
New +$3.37M 1.18% 38
2016
Q1
Sell
-55,000
Closed -$1.24M 104
2015
Q4
$1.24M Buy
+55,000
New +$1.09M 0.52% 55

Other funds holding XENT

Pura Vida Investments's XENT Position: Q3 2021 in Review

Pura Vida Investments sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 531,229 shares — an estimated $9.08M sold.

Pura Vida Investments first reported a position in XENT in Q4 2015 and held it in 21 quarters. The position peaked at $19.6M in Q4 2020. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Pura Vida Investments reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Pura Vida Investments sold 531,229 Intersect ENT, Inc shares in Q3 2021, an estimated $9.08M.
  • Pura Vida Investments first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 21 quarters.
  • Pura Vida Investments's Intersect ENT, Inc position peaked at $19.6M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.